Cleared Traditional

K181870 - Infusion Sets with Precision Filter for...

K181870 is the FDA 510(k) clearance for Infusion Sets with Precision Filter for... by Wuhan W.E.O Science & Technology Development Co., Ltd.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 229-day FDA review.

K181870 · Wuhan W.E.O Science & Technology Development Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2019
Decision
229d
Days
Class 2
Risk

K181870 is an FDA 510(k) clearance for the Infusion Sets with Precision Filter for Single Use, Precision Infusion Filter.... Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Wuhan W.E.O Science & Technology Development Co., Ltd. (Wuhun, CN). The FDA issued a Cleared decision on February 26, 2019 after a review of 229 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Wuhan W.E.O Science & Technology Development Co., Ltd. devices

Submission Details

510(k) Number K181870 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2018
Decision Date February 26, 2019
Days to Decision 229 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 129d · This submission: 229d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 445
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K181870.
K-Shield Advantage Port Access Infusion Set (PAIS)
K190233 · Kawasumi Laboratories, Inc. · May 2019
HIgH-Flo Super26 Subcutaneous Needle Sets
K180843 · Repro-Med Systems, Inc. Dba Rms Medical Products · Apr 2019
Velano Vascular Q2 Extension Set
K182897 · Velano Vascular · Mar 2019
Tamper Evident Cap with Male Luer Lock
K182545 · International Medical Industries, Inc. · Jan 2019
BD FlowSmart Set/MiniMed Pro-Set
K181718 · Becton, Dickinson and Company · Oct 2018
AMSafe Sure-Lok Needle-Free Connector
K173665 · Amsino International, Inc. · Sep 2018